Thursday, February 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stock Targets

Czech National Bank Increases Holdings in Oracle as Insiders Sell Shares

Roberto by Roberto
July 2, 2023
in Stock Targets
0
ANGL stock news
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Czech National Bank Bolsters Holdings in Oracle

On June 26, 2023, Czech National Bank announced that it has elevated its holdings in enterprise software provider, Oracle Co. (NYSE:ORCL), by 0.6% in the first quarter of this year. The bank disclosed to the Securities and Exchange Commission (SEC) that it purchased an additional 1,120 shares following which it owned a total of 181,051 company shares worth $16,823,000 at the time of SEC filing.

It is interesting to note that amid such institutional buying activity by Czech National Bank, two board directors sold large quantities of Oracle’s stock. Director Jeffrey Berg disposed of 45,000 ORCL shares on April 3rd for a total value of $4,214,250 since they were traded at an average price of $93.65 per share. Following this transaction, Berg still holds ownership interest in the company with direct holding amounting to 207,409 shares valued at $19,423,852.85.

Moreover,on June 23rd another director named Michael J Boskin also liquidated his position by selling a bulk quantity of i.e.,90K company shares for approximately $10M wherein every share was sold off at an average price of $118.83 each.

Over the last three months insiders have dynamically reduced their aggregate equity stakes in Oracle’s common stock by shedding off as much as approximately ~6 million ORCL shares worth more than $686 million except for PRAG Capital East Bay LLC who instead bought more with adding up new stake originating from purchasing additional ~22k worth nearly around millions USD etching upto ~$2M cumulative investments made into Oracle on aggregate by PRAG Capital after new investments made into their asset portfolio.

The consistent increase in institutional investors’ trust underscores Oracle’s fundamental stability and long-term growth potential thereby attracting newcomers to invest capital into ORCL and indirectly reflecting on the company’s ongoing progress.

Oracle’s share value opened at $118.66 on Monday with a 12-month low of $60.78 and high of $127.54, demonstrating still good momentum in its chart trends for long term prospective investors . It also has a market cap of $322.07 billion, a PE ratio rate at 38.78 and price-to-earnings-growth (PEG) ratio valued at 3.31 and holds a steady beta of 1.00 wherein exactly one stands for which reflects co-relation with broader index movements in the market sphere.

Its stock has a moving average of $104.01 over the last fifty days whereas over the last two hundred days i.e, six months it has average out with moving around ~$93.07 levels indicating significant movements in the short term period as well on an incremental basis from its historical trading levels.

Currently, Oracle soundly maintains quick ratio and current ratio equivalent to 0.91 respectively which poses good liquidity position to capitalize on growth opportunities & manage its potential operations without facing cash crunch.
Investors should keep an eagle eye on how much stash insiders continue selling in lieu of their perceived expectations to maximize their returns as it can directly affect the company’s performance when top level executive offloads major part of his/her equity stake arousing questions among shareholder base and signalling bearish sentiments with increasing skepticism amongst investor fraternity about future prospects ahead.
Our long term recommendation hence accordingly urges investors to carefully analyze these factors before making any headroom or adopting alternative routes while investing in ORCL for hedging risks within their portfolio investment strategy given present economic outlook etched with volatilities & uncertainty ahead from macro perspective until things settle down better than currently stacked up signals albeit they could carry some weightage after accounting relevant factors forming part of investors process.To sail through turbulences amidst calm bullish run continues today requires perfectly calibrated actions & right decision making for long term accruals ,both lucratively and in tandem with the broader market movements.
[bs_slider_forecast ticker=”ORCL”]

Oracle’s Quarterly Earnings Report and Insider Selling: Mixed Reactions from Investors

[stock_market_widget type=”chart” template=”basic” color=”#3946CE” assets=”ORCL” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” api=”yf”]



As the world navigates through constant technological advancements, businesses such as Oracle play a pivotal role in shaping the landscape. Recently, the company announced its quarterly earnings data and exceeded analysts’ consensus estimates of revenue and earnings per share. The enterprise software provider reported $1.67 EPS during Q2 2023, with a net margin of 17.02% and revenues of $13.84 billion.

Following this announcement, several institutional investors have either reduced or increased their stakes in Oracle’s stock. Atlas Wealth LLC, for instance, has acquired a new stake valued at $315,000 while DGS Capital Management LLC lifted their stake by 3.1% after purchasing additional shares worth $326,000.

However, recent insider trading suggests that some of Oracle’s high-ranking personnel might not be so confident in their latest financial reports’ sustainability. Director Jeffrey Berg recently sold 45,000 shares at an average price of $93.65 amounting to $4,214,250.00 and director Michael J Boskin offloaded 90,000 shares priced at an average of $118.83 for a total value of $10,6947,700.

Despite the mixed actions undertaken by stakeholders concerning Oracle’s prospects – with thirteen equities research analysts rating the stock as ‘hold.’ With fourteen ranking it as the buys – Deutsche Bank Aktiengesellschaft raised its target price from $120 to $135 while BMO Capital Markets upped their rating from $96 to $132.

In terms of returns on investment for shareholders who remain bullish on Oracle despite occasional insider selling episodes since April this year: On July 26th will be issued a quarterly dividend payment with investors receiving 40 cents per share resulting in an annualized dividend yield of 1.35%. This payout represents a slightly increased payout ratio of over 52% compared to past years when the ratio has hovered around half that figure.

As of the end of Q2 2023, approximately 43.43% of the company’s shares were held by institutional investors and hedge funds. Nonetheless, until Oracle can demonstrate consistency in its management and earnings reports over a prolonged period, market stakeholders will undoubtedly remain torn on whether to hold or sell Oracle’s stock.

Tags: ORCL
Roberto

Roberto

Related Posts

RLI stock news
Stock Targets

Price T Rowe Associates Inc. Cuts Holdings in Becton, Dickinson and Company as Medical Instruments Supplier Reports Strong Quarterly Earnings

September 14, 2023
MA stock news
Stock Targets

Healthcare of Ontario Pension Plan Trust Fund Increases Holdings in Sun Life Financial Inc. and Announces Quarterly Dividend Increase

September 14, 2023
HBAN stock news
Stock Targets

Fort L.P. Reduces Holdings in A.O. Smith Co. as Industrial Products Company Shows Promising Financial Performance

September 13, 2023
Next Post
USB stock news

Seagen Inc.: Investing in the Future of Cancer Treatment

VCIT stock news

Stonnington Group LLC Invests in Apellis Pharmaceuticals, Inc.: A Promising Biopharmaceutical Investment Opportunity

BMY stock news

Vishria Bird Financial Group LLC Invests in Meta Platforms, Formerly Known as Facebook

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

SKYX Platforms Stock

Marriott Partnership Signals Major Breakthrough for SKYX Platforms

5 months ago
Microsoft Stock

Microsoft’s AI Ambition: A High-Stakes Bet on Future Growth

18 hours ago
Turtle Beach Stock

Turtle Beach Forges PlayStation Alliance with New Gaming Headset

5 months ago
FLO stock news

Cemtrex Shares Surge After Halting Trading Due to Circuit Breaker

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

CureVac Delisted Following BioNTech Acquisition Completion

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

PC Connection Set to Report Full-Year and Fourth Quarter Earnings

Fossil Group Stock Surges Past Key Technical Threshold

NextGen Healthcare: Strategic Wins and Industry Accolades Signal Sustained Momentum

Trending

Rolls Royce Stock
Defense & Aerospace

Rolls-Royce Shares: A Pivotal Period for Growth and Diversification

by Dieter Jaworski
February 5, 2026
0

The coming weeks represent a critical juncture for Rolls-Royce. The company is poised to demonstrate whether it...

Viking Therapeutics Stock

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

February 5, 2026
Solana Stock

Solana Faces Billions in Potential Token Supply Releases

February 5, 2026
CureVac Stock

CureVac Delisted Following BioNTech Acquisition Completion

February 5, 2026
EOS Stock

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

February 5, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Rolls-Royce Shares: A Pivotal Period for Growth and Diversification
  • Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report
  • Solana Faces Billions in Potential Token Supply Releases

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com